From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast No 2: Steve O'Hara is a liar, I am not selling Optibiotix but I cannot honestly advise you to hold

By Tom Winnifrith | Friday 23 May 2025


Disclosure: I own shares in one or more of the stocks mentioned. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


If the Optibiotix (OPTI) boss or his wanker of a chairman wish to sue me go ahead, I have contemporaneous notes and will see you in Court bitchez! I will also be seeing you at the AGM where I will hold you to account.. I explain the three reasons why why I am not selling my shares after today's discounted placing and, I think, misleading press release. But I also explain why I cannot in all good conscience, advise you to hold any more. It must be your call from here.
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

CLAI

CelAI madness begets madness

Monday »

ICON

Iconic Labs, the world has gone mad!

Time left: 16:11:09